Extract notice to the Minister
Nucala
Common name / Subject : mépolizumab
Name of the manufacturer : GSK
Form : Pd. Inj. S.C.
Dosage : 100 mg
Name of the manufacturer : GSK
Form : Pd. Inj. S.C.
Dosage : 100 mg
Indication : Asthme éosinophilique grave
INESSS' Recommendation
-
Minister's decisions
Inscrire aux listes des médicaments – Médicament d’exception
Evaluation published on February 01, 2018